Withings UK & North American Media Contact:
Ian Twinn | Tandem Marketing
Communications
iantwinn@tandemcomms.com

Withings Announces FDA Clearance of its Highly Anticipated Body Scan Health Station
Body Scan connected health station helps users get a handle on health with the ability to measure healthvitals including Segmental Body Composition, Electrodermal Activity alongside a 6-lead medically cleared ECG
via Withings Scan Monitor 2.01.

Issy-les-Moulineaux, France and Boston, US – Aug 28, 2023 – Withings, the pioneer of the connected healthmovement, today announced that its revolutionary Body Scan Connected Health Station has received FDA
clearance, via Withings Scan Monitor 2.01 and will be available this fall in the US priced at $399.95.
Body Scan with Withings Scan Monitor 2.0 is the world’s first health station to receive FDA clearance for thedetection of atrial fibrillation through the acquisition of a 6-Lead ECG.
Body Scan provides daily analysis of biomarkers associated with common health conditions. With the abilityto monitor segmental body composition, heart rate, and vascular age, it further advances the smart scale
category. With measurements that will detect atrial fibrillation via a 6-lead ECG and also assess nerve activity,
Body Scan goes beyond weight management to become an unprecedented in-home connected health stationthat can help users take proactive control over their health.
Winner of three CES 2022 Innovation Honoree Awards, Body Scan will also allow users to access coaching,clinical specialists and personalized, holistic plans in-app to help them reach their health goals. Developedwith specialists in cardiovascular, neurologic, and metabolic conditions, these programs will provide users
with important insights based on well-known metrics and the ability to be connected with medical specialists
in case of health concerns.
Body Scan consists of a single high strength tempered glass platform with an integrated retractable handle.
Body Scan contains four weight sensors and 14 ITO electrodes within the platform and 4 stainless steel
electrodes in the handle for 6-lead ECG and segmental body composition analysis. It features a long-life
rechargeable battery that offers 12 months of use and includes a large high resolution 3.2” LCD color screenthat displays stats.
1Withings Scan Monitor 2.0 is the FDA cleared device name of Withings Body Scan when the ECG function has
been activated by the user. Currently Withings Scan Monitor 1.0 allows ScanWatch 1 to enable an on-wrist
1-lead ECG.

“Withings created the connected health category back in 2009 and today is proud to be the number one
selling smart scale manufacturer in the United States, helping millions of users manage their weight,” said Eric
Carreel, Withings Founder and President. “With Body Scan, we will turn the morning weigh-in into asophisticated home health check with access to holistic health data and personal health programs created by
medical professionals. We will empower our users with the ability to take meaningful actions based on
medical-grade data, adding a new dimension to ongoing lifestyle and chronic condition management throughthe ultimate in-home health experience.”
Best-in-class weight monitoring and segmental body composition
Body Scan will provide a precise (accurate to 0.1lbs / 50 grams) weight management experience thanks to its
advanced weight sensors and unique retractable handle form factor. For the first time, a Withings scale
integrates the breakthrough technology of segmental body composition allowing a never-seen level ofprecision for body composition monitoring.
Body Scan will also be able to measure Basal Metabolic Rate (BMR). BMR is the number of calories the bodyburns at rest, and it provides valuable information about the user's overall metabolic health. By measuring
BMR, users can better understand their overall health and make informed decisions about their diet andexercise. The connected health station also uses this to calculate metabolic age, comparing how many calories
a body burns at rest with others in an age group.
With electrodes placed in the base of the device and in the handle, Body Scan uses multi-frequency
Bioelectrical Impedance Analysis (BIA) to measure overall body composition. It measures whole-body fat andwater percentage, visceral fat, muscle and bone mass and provides readings for individual body parts,including torso, arms, and legs.
A very low level, safe electrical signal is sent from the electrodes on the scale and within the handgrip.
Withings’ scientifically developed algorithm identifies resistance, known as impedance, to measure precise
body composition in less than three seconds.
Often used by health experts and sports professionals, segmental body composition allows the smallest
changes in body composition to be identified and monitored over time. Doing so identifies fat mass
distribution, informs users of potential health risks associated with localized fat findings, and efficiently spots
muscle imbalances. Withings democratizes this technology bringing it out of the sports lab and into the home.
Electrodermal Activity Monitoring
Developed with experts from Impeto Medical, Body Scan will track sweat gland activity in the feet andprovide daily assessment of small nerve activity. The measurement is designed to be performed in under 20
seconds by applying a small direct current via the electrodes located in the plate. It will provide a reading as
an easy-to-understand score (computed from an Electrochemical Skin Conductance) delivered to the user via
the device screen and the Withings App.
Sweat is triggered by the small nerves that are innervating the sweat glands. Sudomotor function can beevaluated by measuring the ability of the feet sweat glands to release chloride ions in response to anelectrical stimulus. An impaired sudomotor function is a sign of reduced sweat gland innervation linked to adegeneration of small nerve fibers.
Lifestyle changes, such as healthy eating and getting regular activity, can be effective in improving nerve
activity for a healthy lifestyle. To help users adopt healthy habits and affect change, the Withings app also
provides access to actionable insights and personalized plans.
Every Day At Home Heart HealthWith cardiovascular conditions often linked to weight issues, Body Scan is designed to seamlessly offer avariety of cardiovascular measurements at every weigh-in. The upcoming features include: heart rate, ECG
recordings, and vascular age.
Body Scan via Withings Scan Monitor 2.01 will record a 6-lead ECG via two sets of electrodes located on eachside of the handle and one within the base of the scale. The proprietary embedded algorithm is designed to
identify and track heart patterns associated with atrial fibrillation, allowing results to be displayed directly onthe device’s LCD screen and the accompanying app. Readings can be stored to show trends over time andshared with medical professionals from the app.
Vascular Age will provide a daily, easy-to-understand assessment of arterial health and overall wellness. It
accomplishes this by showing people how their cardiovascular health compares to the norms expected within
their age bracket, using an estimate of their inner vascular age. Vascular Age is a patented technology
developed by Withings.

Availability
Developed by doctors specializing in cardiovascular, neurologic, and metabolic conditions, Priced at $399.95,
Body Scan comes in black and will be available from the end of September 2023. Body Scan will come with athree-month subscription to Withings+ the health improvement programs available in the free Withings app.
-endsAbout Withings
Withings created the first smart scale in 2009 and has been the pioneer in connected health ever since. Its
clinically validated and multi award-winning range is used by millions worldwide, and includes smart scales,
hybrid watches, blood pressure monitors, sleep analyzers and more. The team of engineers, data scientists,and healthcare professionals at Withings work alongside clinical experts to make it possible to takemedical-grade measurements at home. Withings was the first to bring measurements for pulse wave velocity
and electrodermal activity into the home – finding ever more precise ways to measure our health. Withings
Health Solutions, its dedicated division serving healthcare professionals across chronic disease prevention andmanagement, remote patient monitoring, clinical research and more helps bridge the gap between patientsand their care teams.
Withings is dedicated to creating a world where people can see their path to better health, and feel
supported to pursue it using devices designed to fit beautifully into daily life, supported by information that
unlocks long-term health insights and offers programs to create meaningful change.
Find out more at withings.com and connect with us on Facebook, Instagram or Twitter.
About Impeto Medical
Impeto Medical is a French company created in 2005 specializing in the research, development, production
and sales of innovative medical devices, especially in the field of detection and monitoring of peripheral
neuropathies.
With more than thousands of Sudoscan products sold worldwide, Impeto Medical sets a new standard in thefield of detection and monitoring of small fiber neuropathies from the doctor's office, particularly important
for the prevention of serious complications such as diabetes and several neurological diseases. For the very
first time, Sudoscan is integrated into an in-home device allowing the general public to have a comprehensive
result of their nerve activity through a simple weight-in. As of November 20, 2021, Impeto Medical's activities
have been completely sold to Withings company.